FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称GEPTANOLIMAB
异名/同义词APL-501
CBT-501
GB226
GB-226
GENOLIMZUMAB
GEPTANOLIMAB
GEPTANOLIMAB [INN]
GEPTANOLIMAB [WHO-DD]
HUMANIZED IGG4 ANTIBODY DIRECTED AGAINST THE NEGATIVE IMMUNOREGULATORY HUMAN CELL SURFACE RECEPTOR PROGRAMMED CELL DEATH 1 (PD-1/PDCD1/PD1) WITH LOW ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY AND COMPLEMENT-DEPENDENT CYTOTOXICITY
MMUNOGLOBULIN G4 (232-PROLINE,DE-451-LYSINE), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN-MUS MUSCULUS MONOCLONAL GB226 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GB226 .KAPPA.-CHAIN, DIMER
CAS登记号2348469-43-0
物质唯一标识(Unique Ingredient Identifier)FME52R2SGN
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System